130 related articles for article (PubMed ID: 16548673)
21. Depression and Chronic Obstructive Pulmonary Disease: Treatment Trials.
Borson S; Claypoole K; McDonald GJ
Semin Clin Neuropsychiatry; 1998 Apr; 3(2):115-130. PubMed ID: 10085198
[TBL] [Abstract][Full Text] [Related]
22. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease].
Devillier P; Salvator H; Roche N; Grassin-Delyle S; Naline E; Dorocant S; Neveu H
Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634
[TBL] [Abstract][Full Text] [Related]
23. Management of chronic obstructive pulmonary disease in Swiss primary care: room for improvement.
Steurer-Stey C; Dallalana K; Jungi M; Rosemann T
Qual Prim Care; 2012; 20(5):365-73. PubMed ID: 23114004
[TBL] [Abstract][Full Text] [Related]
24. End stage chronic obstructive pulmonary disease.
Ambrosino N; Gherardi M; Carpenè N
Pneumonol Alergol Pol; 2009; 77(2):173-9. PubMed ID: 19462352
[TBL] [Abstract][Full Text] [Related]
25. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Evans DJ; Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
[TBL] [Abstract][Full Text] [Related]
26. Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources.
Pierson DJ
Respir Care; 2006 Mar; 51(3):277-88. PubMed ID: 16533418
[TBL] [Abstract][Full Text] [Related]
27. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003.
O'Donnell DE; Aaron S; Bourbeau J; Hernandez P; Marciniuk D; Balter M; Ford G; Gervais A; Goldstein R; Hodder R; Maltais F; Road J;
Can Respir J; 2003; 10 Suppl A():11A-65A. PubMed ID: 12861361
[TBL] [Abstract][Full Text] [Related]
28. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
[TBL] [Abstract][Full Text] [Related]
29. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Chong J; Cates CJ
Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
[TBL] [Abstract][Full Text] [Related]
30. COPD 2013: an update on treatment and newly approved medications for pharmacists.
Meyer KC
J Am Pharm Assoc (2003); 2013; 53(6):e219-29; quiz e230-1. PubMed ID: 24185438
[TBL] [Abstract][Full Text] [Related]
31. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?
Reddy CB; Kanner RE
Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532
[TBL] [Abstract][Full Text] [Related]
32. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
[TBL] [Abstract][Full Text] [Related]
33. Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines.
Lodewijckx C; Sermeus W; Vanhaecht K; Panella M; Deneckere S; Leigheb F; Decramer M
J Eval Clin Pract; 2009 Dec; 15(6):1101-10. PubMed ID: 20367712
[TBL] [Abstract][Full Text] [Related]
34. Treatment of stable chronic obstructive pulmonary disease: the GOLD guidelines.
Lee H; Kim J; Tagmazyan K
Am Fam Physician; 2013 Nov; 88(10):655-63, 663B-F. PubMed ID: 24364481
[TBL] [Abstract][Full Text] [Related]
35. Screening for Chronic Obstructive Pulmonary Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Guirguis-Blake JM; Senger CA; Webber EM; Mularski RA; Whitlock EP
JAMA; 2016 Apr; 315(13):1378-93. PubMed ID: 27046366
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue Française.
Zysman M; Chabot F; Devillier P; Housset B; Morelot-Panzini C; Roche N;
Rev Mal Respir; 2016 Dec; 33(10):911-936. PubMed ID: 27890625
[TBL] [Abstract][Full Text] [Related]
37. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
38. Non-pharmacological treatment for chronic obstructive pulmonary disease.
Clini E; Costi S; Lodi S; Rossi G
Med Sci Monit; 2003 Dec; 9(12):RA300-5. PubMed ID: 14646985
[TBL] [Abstract][Full Text] [Related]
39. Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options.
Friedman M; Hilleman DE
Pharmacoeconomics; 2001; 19(3):245-54. PubMed ID: 11303413
[TBL] [Abstract][Full Text] [Related]
40. Chronic obstructive pulmonary disease treatment options.
George DL
J Manag Care Pharm; 2004 Jul; 10(4 Suppl):S11-6. PubMed ID: 15253682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
